Trial intelligence / Profile preview

Esomeprazole for Chronic Posterior Laryngitis

NCT00628667Phase 4Completed

Sponsor
AstraZeneca
Start
Feb 2002
Primary completion
Mar 2003
Modality
Small Molecules
01

Overview

A Phase 4 trial of esomeprazole in chronic posterior laryngitis (PL), sponsored by AstraZeneca. Started Feb 2002; status: completed.

02

Drugs

esomeprazole
03

Conditions

chronic posterior laryngitis (PL)

Beyond the preview

Go deeper on NCT00628667.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00628667.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call